Ovarian cancer, historically challenging to diagnose due to vague early symptoms, often reaches advanced stages before ...

The most common surgical complications in obese patients with epithelial ovarian cancer (EOC) include wound infection, ...

The grade of your cancer cells – which rates how much they look like healthy cells and can predict how they’ll act – plays a role. Epithelial ovarian cancers, which account for 90% of all ...

Results from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can ...

Patients with advanced epithelial ovarian cancer who were non-Hispanic Black, older, had lower household income, resided in ...

Antibody-drug conjugates and their development remains a central theme in ongoing research within the realm of ovarian cancer ...

The University of Cincinnati Cancer Center's Thomas Herzog, MD, the study's first author, said epithelial ovarian cancer often initially responds to chemotherapy treatment and then enters a period ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on ...

Standard therapy for newly diagnosed advanced epithelial ovarian cancer is cytoreductive surgery combined with paclitaxel-carboplatin chemotherapy with or without bevacizumab. In the phase II ...

Patients in the pembrolizumab-olaparib arm had clinically meaningful improvements in PFS over patients in the control arm.